Content by American Association for the Advancement of Science

|4 min read

Researcher Who Solved a 50-Year Mystery Wins Science & SciLifeLab Prize

Scientist uncovers machinery that makes a molecule with protective effects against various disorders
|2 min read

Mpox Virus Continues to Evolve through Human Transmission

Several mutations in mpox prove that the virus sustained human-to-human transmission, not just zoonotic spillover
|1 min read

The Monkeypox Virus DNA-Synthesizing Machine

The authors hope this finding could lead to designs for new treatments
|2 min read

Proteins Could Offer Risk Markers and Therapy Targets in Diabetic Kidney Disease

A longitudinal study of diabetics has linked three proteins with a slower progression of diabetic kidney disease
|1 min read

Structural Insights into How an Early SARS-CoV-2 Variant Gained Its Advantage

Using cryo-electron microscopy, researchers investigated the structural basis for the spread of a dominant strain
|2 min read

Uncovering SARS-CoV-2 Spike Protein Deletions That Drive Antibody Escape

Researchers have identified a pattern of SARS-CoV-2 spike protein deletions that can prevent antibody binding
|2 min read

BioNTech–Pfizer mRNA Vaccine Largely Effective against UK Variant

Researchers found no loss of immune protection compared to that against the original Wuhan reference strain
|2 min read

A Saliva-Based Smartphone Platform Could Rapidly Expand COVID-19 Testing

A smartphone-read ultrasensitive and quantitative saliva test for COVID-19 can provide results within 15 minutes
|1 min read

How SARS-CoV-2 Protein Interferes with Host Anti-Viral Immunity

Targeting the interaction of this protein, Nsp1, with the host may be an important therapeutic strategy, the authors of a recent study say
|2 min read

Study of COVID-19 Patients Reveals Distinct 'Immunotypes'

As the global COVID-19 pandemic continues, researchers continue to investigate the characteristics of the human immune response in fighting it
|1 min read

Immune Analysis Uncovers 'Hallmark' of Severe COVID-19

In a study of 50 COVID-19 patients, researchers have discovered new insights into why some people progress to severe or critical disease
|2 min read

New CAR T Cells Could Help Avoid Patient Relapse in Blood Cancers

Up to 30 percent of patients with B cell malignancies such as lymphoma relapse after CAR T cell treatment, partly because their lymphoma cells stop expressing the target antigen
Page 1 of 2